NextCure, Inc.
NXTCBiotechnology
$6.53+2.92%As of Oct 29vs prior close
- Market cap
- $29.9M
- P/E (TTM)
- –
- P/E (FY1)
- -1.4×
- From 52W high
- −54.27%
- EPS (LTM)
- -$8.33
- Revenue (YE20)
- $22.4M
Nomior Score
30
Steady ProfileSpeculativeBottom 15% of the scored universe
Growth—
Quality30
Value—
Momentum31
Resilience34
Growth
+252.58%revenue a year over 1 fiscal year
YE19 $6.3MYE20 $22.4M
Connections
Revenue to profitYE20
The operating loss was 184% of revenue, narrower by 406 pts on a year.
Who owns it
1fund